SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019879
Filing Date
2022-05-12
Accepted
2022-05-12 16:18:50
Documents
53
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q asmb-10q_20220331.htm   iXBRL 10-Q 1911242
2 EX-31.1 asmb-ex311_7.htm EX-31.1 18288
3 EX-31.2 asmb-ex312_8.htm EX-31.2 18182
4 EX-32.1 asmb-ex321_9.htm EX-32.1 8342
5 EX-32.2 asmb-ex322_11.htm EX-32.2 8271
  Complete submission text file 0001564590-22-019879.txt   7196612

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA asmb-20220331.xsd EX-101.SCH 37210
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asmb-20220331_cal.xml EX-101.CAL 39574
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asmb-20220331_def.xml EX-101.DEF 136333
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE asmb-20220331_lab.xml EX-101.LAB 319953
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asmb-20220331_pre.xml EX-101.PRE 242980
47 EXTRACTED XBRL INSTANCE DOCUMENT asmb-10q_20220331_htm.xml XML 1607803
Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35005 | Film No.: 22918086
SIC: 2834 Pharmaceutical Preparations